Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

AstraZeneca
Mallinckrodt
Farmers Insurance
US Army
Fish and Richardson
Johnson and Johnson
QuintilesIMS
Boehringer Ingelheim
Harvard Business School

Generated: December 12, 2018

DrugPatentWatch Database Preview

DESFLURANE - Generic Drug Details

« Back to Dashboard

What are the generic sources for desflurane and what is the scope of desflurane patent protection?

Desflurane is the generic ingredient in two branded drugs marketed by Shanghai Hengrui and Baxter Hlthcare, and is included in two NDAs. Additional information is available in the individual branded drug profile pages.

There are three drug master file entries for desflurane. Three suppliers are listed for this compound.

Pharmacology for DESFLURANE
Drug ClassGeneral Anesthetic
Physiological EffectGeneral Anesthesia
Synonyms for DESFLURANE
(+-)-2-Difluoromethyl 1,2,2,2-tetrafluoroethyl ether
1-(difluoromethoxy)-1,2,2,2-tetrafluoroethane
1,1,1,2-tetrafluoro-2-(difluoromethoxy)ethane
1,2,2,2-Tetrafluoroethyl difluoromethyl ether
2-(difluoromethoxy)-1,1,1,2-tetrafluoroethane
57041-67-5
5829AE
AC1L274J
AC1Q4ICY
AK129759
AKOS006228397
C-04968
C07519
C3H2F6O
CC-26789
CHEBI:4445
CHEMBL1200733
CHF2OCHFCF3
CTK5A6200
D00546
D0H4GN
DB01189
Desfluran-O
Desflurane (JAN/USP/INN)
Desflurane [USAN:INN]
Desflurane [USAN:USP:INN:BAN]
Desflurano
Desflurano [INN-Spanish]
Desfluranum
Desfluranum [INN-Latin]
difluoromethyl 1,2,2,2-tetrafluoroethyl ether
DPYMFVXJLLWWEU-UHFFFAOYSA-N
Ethane, 2-(difluoromethoxy)-1,1,1,2-tetrafluoro-
Ethane, 2-(difluoromethoxy)-1,1,1,2-tetrafluoro-, (+-)-
Ethane,2-(difluoromethoxy)-1,1,1,2-tetrafluoro-
FCH917950
FT-0624525
GTPL7156
I 653
I-653
I14-29587
I653
KB-224010
LS-65505
MFCD00236716
MolPort-001-776-387
OR002154
OR168813
PC6781E
r-e 236ea1
SBB088129
SC-62385
SCHEMBL62917
Suprane
Suprane (TN)
TR-019952
VZ31862
ZX-AP005907

US Patents and Regulatory Information for DESFLURANE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Baxter Hlthcare SUPRANE desflurane LIQUID;INHALATION 020118-001 Sep 18, 1992 AN RX Yes Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Shanghai Hengrui DESFLURANE desflurane LIQUID;INHALATION 208234-001 Feb 26, 2018 AN RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Expired US Patents for DESFLURANE

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Baxter Hlthcare SUPRANE desflurane LIQUID;INHALATION 020118-001 Sep 18, 1992 ➤ Sign Up ➤ Sign Up
Baxter Hlthcare SUPRANE desflurane LIQUID;INHALATION 020118-001 Sep 18, 1992 ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Medtronic
Federal Trade Commission
Deloitte
Farmers Insurance
Cipla
Queensland Health
Express Scripts
Colorcon
US Department of Justice

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.